Scientists track COVID-19's hidden impact on cystic fibrosis patients
NCT ID NCT05745948
Summary
This study aimed to understand how people with cystic fibrosis (CF) respond to COVID-19. Researchers followed 75 children and adults with CF for two years, checking their blood for COVID-19 antibodies from infection or vaccination. The goal was to see how common infections were, if they caused different symptoms in CF patients, and how antibody levels changed over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitari Vall d'Hebron. Cystic Fibrosis Unit
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.